The next board meeting for Werewolf Therapeutics Inc is on 21 Mar 2025 for the purpose of Werewolf Therapeutics Inc Fourth Quarter Earnings Results for 2024See details
Werewolf Therapeutics Inc has a share price target of US$ 11, revenue growth forecast of -36.5%, and profit growth estimate of -10.8% for FY25, based on top 6 analyst calls.